ProShare Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-23,690
| Closed | -$118K | – | 1782 |
|
|
2016
Q3 | $118K | Sell |
23,690
-4,390
| -16% | -$21.9K | ﹤0.01% | 1406 |
|
|
2016
Q2 | $143K | Buy |
28,080
+434
| +2% | +$2.21K | ﹤0.01% | 1484 |
|
|
2016
Q1 | $158K | Sell |
27,646
-2,838
| -9% | -$16.2K | ﹤0.01% | 1460 |
|
|
2015
Q4 | $316K | Buy |
30,484
+2,398
| +9% | +$24.9K | ﹤0.01% | 1269 |
|
|
2015
Q3 | $519K | Sell |
28,086
-1,799
| -6% | -$33.2K | 0.01% | 927 |
|
|
2015
Q2 | $582K | Sell |
29,885
-1,433
| -5% | -$27.9K | 0.01% | 1030 |
|
|
2015
Q1 | $551K | Buy |
31,318
+4,525
| +17% | +$79.6K | 0.01% | 1132 |
|
|
2014
Q4 | $428K | Buy |
26,793
+1,587
| +6% | +$25.4K | 0.01% | 1287 |
|
|
2014
Q3 | $317K | Sell |
25,206
-4,802
| -16% | -$60.4K | ﹤0.01% | 1682 |
|
|
2014
Q2 | $469K | Sell |
30,008
-12,686
| -30% | -$198K | 0.01% | 1625 |
|
|
2014
Q1 | $561K | Buy |
42,694
+26,618
| +166% | +$350K | 0.01% | 1779 |
|
|
2013
Q4 | $259K | Sell |
16,076
-5,985
| -27% | -$96.4K | ﹤0.01% | 1204 |
|
|
2013
Q3 | $367K | Buy |
22,061
+5,070
| +30% | +$84.3K | 0.01% | 1733 |
|
|
2013
Q2 | $171K | Buy |
+16,991
| New | +$171K | ﹤0.01% | 2097 |
|